JasonG.ZittelMD

Geriatrics • Rochester, NY

Physician

Join to view full profile

Dr. Zittel is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Zittel's full profile

Already have an account?

Office
601 Elmwood Ave
Rochester, NY 14642
Phone+1 585-275-5823

Fax+1 585-273-1051

Education & Training

University of RochesterFellowship, Geriatric Medicine (Internal Medicine), 2016 - 2017
University of RochesterResidency, Internal Medicine, 2012 - 2015
Pennsylvania State University College of MedicineClass of 2012

Certifications & Licensure

NY State Medical License 2015 - 2026
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Geriatric Medicine
American Board of Internal Medicine Medical Oncology

Clinical Trials

BMS-813160 With Nivolumab and Gemcitabine and Nab-paclitaxel in Borderline Resectable and Locally Advanced Pancreatic Ductal Adenocarcinoma (PDAC) Start of enrollment: 2018 Aug 31
Active, not recruiting
Phase 1, Phase 2

Publications & Presentations

PubMed

Barriers to participation in clinical trials of rural older adult cancer survivors: A qualitative study.
Evelyn Arana-Chicas, Laura M Hincapie Prisco, Saloni Sharma, Fiona Stauffer, Serge Dauphin
The Journal of Rural Health. 2025-01-01
2 citations
Geriatric assessment for the practicing clinician: The why, what, and how.
Allison Magnuson, Kah Poh Loh, Fiona Stauffer, William Dale, Nikesha Gilmore
CA. 2024-08-29
Efficacy of trastuzumab deruxtecan in treating HER2-low breast cancer leptomeningeal metastasis: a case report.
Zeni Kharel, Sarah Stanford, Lauryn E Hemminger, Tyler Schmidt, Sara J Hardy
Personalized Medicine. 2024-01-01

Lectures

A phase II study of enzalutamide (Enz) with dutasteride (Dut) or finasteride (Fin) in men ≥ 65 years with hormone-naive systemic prostate cancer (HNSPCa): Tolerability...
ASCO Annual Meeting 2019 - Chicago, IL - 5/31/2019

Press Mentions

Whether You Feel 73 or 37, Age Perception Alone Does Not Spur Treatment DecisionsDecember 19th, 2018
American Society of Clinical Oncology Honors Wilmot Physician with National AwardMay 23rd, 2018
Cancer in Rural Upstate New York: Study Reveals Obstacles, Opportunities for CareFebruary 1st, 2024